Verseon Corp (LON:VSN) insider Fodor,Eniko acquired 6,000 shares of the company’s stock in a transaction dated Wednesday, September 21st. The shares were bought at an average cost of GBX 161 ($2.10) per share, with a total value of £9,660 ($12,609.32).
Verseon Corp (LON:VSN) opened at 166.00 on Monday. The stock’s 50 day moving average is GBX 161.00 and its 200-day moving average is GBX 163.08. The firm’s market cap is GBX 251.30 million. Verseon Corp has a 1-year low of GBX 148.00 and a 1-year high of GBX 228.50.
Verseon Corp Company Profile
Verseon Corporation is a pharmaceutical company. Its platform is capable of modeling interactions between a protein and a drug molecule with precision sufficient for designing drug candidates. The Company operates through pharmaceutical research segment. The Company uses its drug discovery technology to develop a portfolio of programs targeting disease areas consisting of anti-coagulation, diabetic macular edema (DMA) and oncology.
Receive News & Ratings for Verseon Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verseon Corp and related companies with MarketBeat.com's FREE daily email newsletter.